Cancer Family
Urinary System Neoplasm
CI-CAN-00000379Explore in graph →
Non-malignant965 active trials28 approved drugs109 evidence items
- NCIt
- C3431
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000379Explore in graph →
Clinical trials
4,240 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04392076 | Image Guided RFA/MWA/CRYO of RCC Biomarker Profile Study | unknown | — | 43 | University of LeedsOTHER | 1 | May 19, 2020 | clinicaltrials |
| NCT04385654 | Toripalimab Combined With Axitinib as Neoadjuvant Therapy for Advanced/Metastatic Non-clear Cell Renal Cell Carcinoma | unknown | Phase 2 | 40 | West China HospitalOTHER | 0 | May 13, 2020 | clinicaltrials |
| NCT04146831 |
| Sintilimab in FH-deficient Renal Cell Carcinoma |
| unknown |
| Phase 2 |
| 37 |
| West China HospitalOTHER |
| 0 |
| May 12, 2020 |
| clinicaltrials |
| NCT04385316 | Clinical Study of Gastric Cancer, Colorectal Cancer and Bladder Cancer Based on Liquid Biopsy | unknown | — | 3 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | May 12, 2020 | clinicaltrials |
| NCT01993979 | A Phase III Randomised Trial of Peri-Operative Chemotherapy Versus sUrveillance in Upper Tract Urothelial Cancer (POUT)(POUT) | unknown | Phase 3 | 261 | Institute of Cancer Research, United KingdomOTHER | 1 | May 4, 2020 | clinicaltrials |
| NCT03259477 | RFR Change of Precise Segmental Versus Complete Renal Arterial Clamping During LPN for Clinical T1 RCC | unknown | N/A | 100 | Xuanwu Hospital, BeijingOTHER | 1 | Apr 29, 2020 | clinicaltrials |
| NCT02070120 | Investigating Bladder Chemotherapy Instead of Surgery for Low Risk Bladder Cancer(CALIBER) | unknown | Phase 2 | 82 | Institute of Cancer Research, United KingdomOTHER | 1 | Mar 19, 2020 | clinicaltrials |
| NCT04295967 | Vasculogenic Mimicry in Urothelial Carcinoma | unknown | — | 70 | Assiut UniversityOTHER | 0 | Mar 5, 2020 | clinicaltrials |
| NCT04268368 | Immune Related-adverse Events in Patients Receiving Immune Checkpoint Inhibitors(ICI-DISCOVER) | unknown | — | 200 | Università Politecnica delle MarcheOTHER | 1 | Feb 17, 2020 | clinicaltrials |
| NCT04264936 | A Study of RC48-ADC(Antibody Drug Conjugate) and JS001 to Evaluate the Safety and Pharmacokinetics of Subjects With Locally Advanced or Metastatic Urothelial Cancer | unknown | Phase 1 / Phase 2 | 36 | Peking University Cancer Hospital & InstituteOTHER | 1 | Feb 13, 2020 | clinicaltrials |
| NCT03522155 | Patient-Centered Communication of Life Expectancy Estimates in Genitourinary Malignancies | unknown | N/A | 136 | Cedars-Sinai Medical CenterOTHER | 1 | Feb 6, 2020 | clinicaltrials |
| NCT04245618 | Neoadjuvant Chemotherapy in Non Muscle Invasive T1b Bladder Cancer | unknown | — | 50 | Assiut UniversityOTHER | 0 | Jan 30, 2020 | clinicaltrials |
| NCT02928692 | Minocycline Attenuate Postoperative Cognitive Dysfunction and Delirium(MAPOCD) | unknown | Phase 3 | 750 | RenJi HospitalOTHER | 1 | Jan 28, 2020 | clinicaltrials |
| NCT03571438 | Evaluation of a Promising New Combination of Protein Kinase Inhibitors on Organotypic Cultures of Human Renal Tumors(COMBOREIN) | unknown | N/A | 100 | University Hospital, GrenobleOTHER | 1 | Jan 18, 2020 | clinicaltrials |
| NCT04228198 | Protocol of the Italian Radical Cystectomy Registry | unknown | — | 1,000 | University of Roma La SapienzaOTHER | 1 | Jan 14, 2020 | clinicaltrials |
| NCT03739177 | Onco4D(TM) Biodynamic Chemotherapy Selection for Bladder Cancer Patients | unknown | — | 150 | Animated Dynamics, Inc.INDUSTRY | 1 | Jan 13, 2020 | clinicaltrials |
| NCT04223063 | Exercise-based Pre-habilitation in Bladder Cancer Patients Prior to Radical Cystectomy: a Feasibility Study | unknown | N/A | 20 | Ross MasonOTHER | 0 | Jan 10, 2020 | clinicaltrials |
| NCT01447199 | The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC) | unknown | — | 2,000 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 7, 2020 | clinicaltrials |
| NCT04213664 | Meta-analysis of the Prognostic Value of Lymphocyte to Monocyte Ratio (LMR) in Non-metastatic Renal Cell Carcinoma.(LMR) | unknown | — | 4,666 | Corporacion Parc TauliOTHER | 1 | Jan 2, 2020 | clinicaltrials |
| NCT03638206 | Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies | unknown | Phase 1 / Phase 2 | 73 | Shenzhen BinDeBio Ltd.INDUSTRY | 1 | Dec 11, 2019 | clinicaltrials |
| NCT04144270 | The Importance of Muscle Function in Patients With Disseminated Bladder Cancer | unknown | — | 30 | Rigshospitalet, DenmarkOTHER | 1 | Nov 20, 2019 | clinicaltrials |
| NCT04148677 | Protoves M1® Syrup in Controlling Adverse Event During HIVEC® Instillations | unknown | — | 100 | Cardarelli HospitalOTHER | 0 | Nov 1, 2019 | clinicaltrials |
| NCT04129606 | Bladder Perforation Post-TURBT: Definition, Incidence and Natural HistoryStudy(TURBT-BP) | unknown | N/A | 300 | Abdelwahab HashemOTHER | 1 | Oct 17, 2019 | clinicaltrials |
| NCT03694912 | Development and Evaluation of High Risk Group Prediction Model in T1 Stage Renal Cell Cancer Using Molecular Biomarkers | unknown | — | 426 | Yonsei UniversityOTHER | 1 | Sep 17, 2019 | clinicaltrials |
| NCT03592199 | Biomarker Study of Pts With Metastatic ccRCC Undergoing Sequential Therapy With 1st Line Sunitinib and 2nd Line Axitinib(SuAx) | unknown | Phase 2 | 7 | Instituto do Cancer do Estado de São PauloOTHER | 1 | Sep 4, 2019 | clinicaltrials |
| NCT04060459 | Paclitaxel-binding Albumin and Cisplatin as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer | unknown | Phase 2 | 50 | Third Military Medical UniversityOTHER | 1 | Aug 19, 2019 | clinicaltrials |
| NCT04060537 | Identification of Novel Biomarkers of Response to Systemic Treatments in Renal Cell Cancer(ARTIST_RCC) | unknown | — | 12 | CCTU- Cancer ThemeOTHER | 0 | Aug 19, 2019 | clinicaltrials |
| NCT03673202 | The Cxbladder Rule-out of Recurrent Urothelial Carcinoma | unknown | — | 300 | London Health Sciences CentreOTHER | 1 | Aug 14, 2019 | clinicaltrials |
| NCT02292914 | Prospective Analysis of Robot-Assisted Surgery | unknown | N/A | 1,120 | Instituto do Cancer do Estado de São PauloOTHER | 1 | Aug 8, 2019 | clinicaltrials |
| NCT04049344 | Decitabine Combined With Oxaliplatin in Patients With Advanced Renal Cell Carcinoma | unknown | Phase 2 | 25 | Zhejiang Cancer HospitalOTHER | 1 | Aug 8, 2019 | clinicaltrials |
| NCT04029948 | Laser vs. Electorsurgical Enbloc Resection of Bladder Tumours | unknown | N/A | 100 | Mansoura UniversityOTHER | 1 | Jul 26, 2019 | clinicaltrials |
| NCT04005820 | Impact of Tumour 1q Gain in French Pediatric and Young Adult Patients With Renal Tumours(UMBRELLA) | unknown | N/A | 510 | Assistance Publique Hopitaux De MarseilleOTHER | 1 | Jul 2, 2019 | clinicaltrials |
| NCT03998371 | Application of UCAD for Diagnosing Urothelial Carcinoma. | unknown | — | 300 | Changhai HospitalOTHER | 1 | Jun 26, 2019 | clinicaltrials |
| NCT03982797 | Treatment of High-risk Non-muscle Invasive Bladder Cancer With IMUNO BGC Moreau RJ as Prophylaxis | unknown | Phase 2 | 306 | Biofabri, S.LINDUSTRY | 1 | Jun 12, 2019 | clinicaltrials |
| NCT03973307 | UroX Biomarker Bladder Cancer Study | unknown | — | 100 | East and North Hertfordshire NHS TrustOTHER_GOV | 1 | Jun 4, 2019 | clinicaltrials |
| NCT03928964 | MEtatastic Renal Carcinoma LINes(MERLIN) | unknown | — | 440 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Apr 30, 2019 | clinicaltrials |
| NCT03667885 | Non-Invasive Diagnostics of Small Renal Masses(NISar) | unknown | — | 160 | Odense University HospitalOTHER | 1 | Mar 19, 2019 | clinicaltrials |
| NCT03122964 | Multi Institutional Study in Patient Presenting With Hematuria | unknown | — | 1,148 | MDx HealthINDUSTRY | 1 | Mar 6, 2019 | clinicaltrials |
| NCT03831321 | The Effect of Preemptive Analgesia On The Comfort Of Patient and Doctor, in Cystoscopy | unknown | Phase 4 | 144 | Taha UçarOTHER | 1 | Feb 5, 2019 | clinicaltrials |
| NCT03796299 | Expression of MCM5 in Urine in Patients With Urothelial Cancers | unknown | — | 180 | Medical University of WarsawOTHER | 1 | Jan 8, 2019 | clinicaltrials |
| NCT03790384 | Sequential Combination Therapy in Bladder Cancer(MITOBCG) | unknown | Phase 4 | 140 | Azienda Ospedaliera "Sant'Andrea"OTHER | 0 | Dec 31, 2018 | clinicaltrials |
| NCT03756207 | Multidisciplinary Bladder-preservation Therapy for Bladder Cancer | unknown | N/A | 80 | Peking University Third HospitalOTHER | 1 | Nov 28, 2018 | clinicaltrials |
| NCT03517332 | Circulating Tumor DNA Exposure in Peripheral Blood | unknown | — | 10,000 | Quantgene Inc.INDUSTRY | 2 | Nov 20, 2018 | clinicaltrials |
| NCT03734614 | Preventive Effects of Aspirin as Adjuvant Therapy in Patients With Locally Advanced Renal Cell Carcinoma | unknown | — | 260 | RenJi HospitalOTHER | 1 | Nov 8, 2018 | clinicaltrials |
| NCT03630692 | Safety and Compliance of Renal Cancer Patients Treated by Non-IV Drugs(TOPTACOS) | unknown | — | 158 | Institut Cancerologie de l'OuestOTHER | 1 | Oct 15, 2018 | clinicaltrials |
| NCT01465425 | Extracolonic Findings on Computed Tomography (CT) Colonography(ACRIN7151) | unknown | — | 520 | American College of Radiology Imaging NetworkNETWORK | 0 | Oct 11, 2018 | clinicaltrials |
| NCT03692533 | Role of Geminin and Mcm-2 in Prognosis of Renal Cell Carcinoma | unknown | N/A | 80 | Assiut UniversityOTHER | 0 | Oct 2, 2018 | clinicaltrials |
Data updated 23 days agoSource updated May 19, 2020source: clinicaltrials